Galapagos' R&D Update 2017: rapidly advancing our product candidates
Galapagos NV - American Depositary Shares (GLPG)
Last galapagos nv - american depositary shares earnings: 10/24 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
glpg.com/company-overview
Company Research
Source: GlobeNewswire
Filgotinib Darwin 3: improved activity, consistent safety parameters for filgotinib Ph2 studies initiated in 6 new indications Cystic fibrosis Three different triple combos in development Successful completion of Ph1 with three individual combo components Start of regulatory process next month, patient study with first triple combo expected to begin in Q4 '17 in Europe Topline data for GLPG1690 in IPF in Q3 '17 Opening of US IND and dosing of first osteoarthritis patient in Phase 1b trial with GLPG1972 Growing number of clinical stage proprietary programs in fibrosis, psoriasis, and other indications Webcast from NY at 14.00 CET/8AM ET tomorrowvia www.glpg.com, +32 2 404 0659, code 8093710 Mechelen, Belgium; 20 June 2017; 7.30 CET, regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces progress made in its R&D strategy and portfolio at its Annual R&D Update on 20 June at 8 AM EDT at the Yale Club in New York City. "I am embold
Show less
Read more
Impact Snapshot
Event Time:
GLPG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GLPG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GLPG alerts
High impacting Galapagos NV - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
GLPG
News
- Galapagos reports first quarter 2024 financial results [Yahoo! Finance]Yahoo! Finance
- Galapagos reports first quarter 2024 financial results GlobeNewswire
- Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024GlobeNewswire
- Galapagos NV (NASDAQ: GLPG) had its "equal weight" rating re-affirmed by analysts at Morgan Stanley. They now have a $38.00 price target on the stock.MarketBeat
- Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024 [Yahoo! Finance]Yahoo! Finance
GLPG
Earnings
- 5/2/24 - Beat
GLPG
Sec Filings
- 5/3/24 - Form 6-K
- 5/2/24 - Form SC
- 5/1/24 - Form 6-K
- GLPG's page on the SEC website